An international research team has developed a “biomechanical well plate” that mimics the lateral line of fish to monitor the heartbeat of lab-grown 3D heart tissue (cardiac organoids) in real time. According to the University of Tokyo, this wireless, sensor-based device allows researchers to scale up drug screening and cardiovascular disease research by monitoring hundreds of organoid pulses simultaneously without traditional, labor-intensive microscopy.
Engineering a “Sixth Sense” for Cardiac Research
The device functions by using fluid dynamics to bridge the gap between biological tissue and electronic sensors. Associate Professor Timothée Mouterde of the University of Tokyo explains that the system utilizes liquid-filled wells with air cavities positioned directly beneath them. As a cardiac organoid beats, it displaces liquid into the air cavity, creating pressure fluctuations that deform a cantilever sensor. This sensor then transmits heartbeat data wirelessly to an app.
This design avoids the need for direct contact between the organoid and the sensor, a common limitation in previous methods. By managing surface tension through analytical computer models, the team ensures the liquid remains in the well without flooding the air cavity. This precision allows the sensor to detect subtle changes in heart rate, rhythm, and strength, providing a look at how tissue responds to external stimuli.
Did you know?
The device is inspired by the lateral line in fish—a sensory organ that detects vibrations and water pressure changes via gelatinous structures called cupula. Researchers adapted this biological principle to translate mechanical pressure from heartbeats into measurable electronic signals.
Moving Beyond 2D Cultures and Animal Models
The field of cardiovascular research has historically relied on 2D cell cultures or animal testing. While these methods provided foundational data, they often struggled to accurately replicate the behavior and responses of the human heart. 3D cardiac organoids, which are bundles of cells typically no bigger than 3 millimeters, offer a more complex and accurate model for studying heart development and disease, according to the research team.
Before this development, studying organoids was often a bottleneck in drug discovery. Many existing methods require growing organoids directly onto sensors, which prevents the reuse of the hardware, or relying on manual microscope observation, which takes time and makes simultaneous testing difficult. The new biomechanical well plate addresses these hurdles by allowing for parallelized testing of various drug concentrations in a reusable format.
Future Trends in Personalized Medicine
The ability to test drugs directly on human tissue represents a shift toward personalized medicine. The biomechanical well plate enables researchers to consider a person’s individual genetics when testing how heart tissue might react to a new treatment.
This cross-disciplinary collaboration—involving experts from Australia, the U.S., and Japan—highlights the importance of combining fluid dynamics and bioengineering to solve pharmacological challenges. By increasing the speed and scale at which researchers can test drug efficacy, the technology paves the way for more individualized therapeutic development.
Frequently Asked Questions
How does the device measure the heartbeat?
The device detects pressure changes in an air cavity caused by the movement of liquid displaced by the beating organoid. This pressure activates a cantilever sensor that sends data wirelessly.
Why is this device better than traditional animal testing?
It allows for the direct testing of treatments on human tissue, which provides more accurate data on how a human heart will respond to a drug compared to animal models.
Can the biomechanical well plates be reused?
Yes. Unlike methods where organoids are grown directly onto sensors, this system keeps the biological and mechanical components separate, making the plates reusable.
Interested in the latest advancements in medical technology? Subscribe to our newsletter for weekly updates on breakthroughs in bioengineering and personalized healthcare.
Worth a look